We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+3.58%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$69.4B
AUM Growth
+$3.54B
Cap. Flow
+$1.44B
Cap. Flow %
2.08%
Top 10 Hldgs %
21.44%
Holding
3,843
New
225
Increased
1,690
Reduced
1,576
Closed
217

Sector Composition

Rank Sector Weight
1 Technology 10.52%
2 Financials 9.29%
3 Healthcare 8.12%
4 Industrials 6.67%
5 Consumer Discretionary 5.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VOT icon
626
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$19.9B
$16M 0.02%
107,017
+4,040
+4% +$589K
VPL icon
627
Vanguard FTSE Pacific ETF
VPL
$8.43B
$15.9M 0.02%
241,331
+24,904
+12% +$1.63M
CSGS
628
DELISTED
CSG Systems International
CSGS
$15.9M 0.02%
326,406
-103,268
-24% -$4.72M
FNV icon
629
Franco-Nevada
FNV
$46B
$15.9M 0.02%
187,686
+39,824
+27% +$3.01M
HBI
630
DELISTED
Hanesbrands
HBI
$15.9M 0.02%
921,810
-36,549
-4% -$630K
TROW icon
631
T. Rowe Price
TROW
$24.3B
$15.9M 0.02%
144,569
-14,344
-9% -$1.51M
IDV icon
632
iShares International Select Dividend ETF
IDV
$8.51B
$15.8M 0.02%
515,879
+6,700
+1% +$208K
SIVB
633
DELISTED
SVB Financial Group
SIVB
$15.8M 0.02%
70,366
-249
-0.4% -$57.6K
WH icon
634
Wyndham Hotels & Resorts
WH
$5.48B
$15.8M 0.02%
282,675
+3,847
+1% +$210K
EWBC icon
635
East-West Bancorp
EWBC
$18B
$15.7M 0.02%
336,340
-9,420
-3% -$451K
PTC icon
636
PTC
PTC
$16B
$15.7M 0.02%
175,038
-9,484
-5% -$850K
MRO
637
DELISTED
Marathon Oil Corporation
MRO
$15.7M 0.02%
1,105,287
-12,993
-1% -$201K
AMTD
638
DELISTED
TD Ameritrade Holding Corp
AMTD
$15.7M 0.02%
314,601
+24,759
+9% +$1.28M
TDOC icon
639
Teladoc Health
TDOC
$1.3B
$15.7M 0.02%
235,810
+22,078
+10% +$1.29M
BNDX icon
640
Vanguard Total International Bond ETF
BNDX
$82.2B
$15.6M 0.02%
272,182
+71,357
+36% +$4.01M
XSD icon
641
State Street SPDR S&P Semiconductor ETF
XSD
$3.04B
$15.6M 0.02%
184,533
-27,611
-13% -$2.26M
FMC icon
642
FMC
FMC
$1.33B
$15.6M 0.02%
187,593
-5,646
-3% -$443K
IJT icon
643
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.42B
$15.4M 0.02%
169,256
+13,912
+9% +$1.25M
HCSG icon
644
Healthcare Services Group
HCSG
$1.53B
$15.4M 0.02%
507,589
+20,631
+4% +$682K
GOVT icon
645
iShares US Treasury Bond ETF
GOVT
$43.6B
$15.4M 0.02%
594,708
+358,853
+152% +$9.09M
APAM icon
646
Artisan Partners
APAM
$3.02B
$15.3M 0.02%
557,010
-2,055
-0.4% -$54.7K
IEUR icon
647
iShares Core MSCI Europe ETF
IEUR
$9.16B
$15.3M 0.02%
328,830
+37,780
+13% +$1.76M
WLY icon
648
John Wiley & Sons Class A
WLY
$2.66B
$15.3M 0.02%
333,426
-3,894
-1% -$177K
FSK icon
649
FS KKR Capital
FSK
$3.44B
$15.3M 0.02%
640,492
+8,661
+1% +$213K
SCZ icon
650
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.7B
$15.3M 0.02%
265,829
-33,246
-11% -$1.92M

Similar funds

Raymond James & Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Raymond James & Associates held 3,843 positions worth $69.4B, up 5.4% from $65.8B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q2 2019 filing shows 225 new, 1,690 increased, 1,576 reduced and 217 closed positions. Its largest new stake was Dow Inc: 851,378 shares worth $42M. The largest sale was AbbVie, an estimated $134M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2019 buy was Dow Inc: 851,378 shares worth $42M.
  • Raymond James & Associates added most to Medtronic in Q2 2019, an estimated $157M increase.
  • Raymond James & Associates's biggest Q2 2019 reduction was AbbVie, cutting an estimated $134M.
  • Raymond James & Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $5.43M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $69.4B portfolio in Q2 2019.
  • Raymond James & Associates opened 225 new positions and closed 217 in Q2 2019.
  • Raymond James & Associates's portfolio value rose 5.4% quarter-over-quarter to $69.4B.

Based on Raymond James & Associates's 13F filing for Q2 2019, filed 6 Aug 2019.